To figure the odds of your long-term success, let's assume the future will be like the past, focusing on the number of times in McQuarrie's database that stocks on a total-return basis either ...

Johnson & Johnson maintained its full-year 2025 adjusted earnings outlook of $10.50 to $10.70 a share, or 6.2% growth from a year ago at the midpoint.

An industry consultant thinks Edward Jones' latest bid to start a bank is an attempt to add revenue sources as the ...